NEXT-Cue

K261805 · Neuroxt, Inc. · QWT · Oct 8, 2026 · Neurology

Device Facts

Record IDK261805
Device NameNEXT-Cue
ApplicantNeuroxt, Inc.
Product CodeQWT · Neurology
Decision DateOct 8, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 882.1454
Device ClassClass 2

Regulatory Classification

Identification

Prognostic assessment software of mild cognitive impairment is a prescription-only device that combines information from multiple clinical data sources to produce an output indicative of the likelihood that a patient diagnosed with mild cognitive impairment will progress to more severe forms of cognitive impairment, or will develop dementia, such as Alzheimer's disease dementia, within a specified period of time. This device is intended for adjunctive use and not intended as a stand-alone diagnostic or prognostic tool.

Special Controls

In combination with the general controls of the FD&C Act, the prognostic assessment software of mild cognitive impairment is subject to the following special controls:

Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...